Maintenance of quality of life in adults with type 1 Gaucher disease previously stabilized on enzyme therapy who were switched to oral eliglustat: 4 year results of the ENCORE trial (2017)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ymgme.2016.11.071
Publication URI: http://dx.doi.org/10.1016/j.ymgme.2016.11.071
Type: Journal Article/Review
Parent Publication: Molecular Genetics and Metabolism
Issue: 1-2